242 related articles for article (PubMed ID: 24709905)
1. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression.
Liberati S; Morelli MB; Amantini C; Farfariello V; Santoni M; Conti A; Nabissi M; Cascinu S; Santoni G
Cells; 2014 Feb; 3(1):112-28. PubMed ID: 24709905
[TBL] [Abstract][Full Text] [Related]
2. Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression.
Liberati S; Morelli MB; Amantini C; Santoni M; Nabissi M; Cardinali C; Santoni G
Curr Protein Pept Sci; 2014; 15(7):732-7. PubMed ID: 25001513
[TBL] [Abstract][Full Text] [Related]
3. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.
Santoni G; Amantini C; Maggi F; Marinelli O; Santoni M; Nabissi M; Morelli MB
Lab Invest; 2020 Feb; 100(2):186-198. PubMed ID: 31653969
[TBL] [Abstract][Full Text] [Related]
4. TRPV2: A Cancer Biomarker and Potential Therapeutic Target.
Siveen KS; Nizamuddin PB; Uddin S; Al-Thani M; Frenneaux MP; Janahi IA; Steinhoff M; Azizi F
Dis Markers; 2020; 2020():8892312. PubMed ID: 33376561
[TBL] [Abstract][Full Text] [Related]
5. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
[TBL] [Abstract][Full Text] [Related]
6. The Transient Receptor Potential Vanilloid Type-2(TRPV2) Ion Channels in Neurogenesis andGliomagenesis: Cross-Talk between TranscriptionFactors and Signaling Molecules.
Santoni G; Amantini C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30845786
[TBL] [Abstract][Full Text] [Related]
7. The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses.
Santoni G; Farfariello V; Liberati S; Morelli MB; Nabissi M; Santoni M; Amantini C
Front Immunol; 2013; 4():34. PubMed ID: 23420671
[TBL] [Abstract][Full Text] [Related]
8. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
Morelli MB; Offidani M; Alesiani F; Discepoli G; Liberati S; Olivieri A; Santoni M; Santoni G; Leoni P; Nabissi M
Int J Cancer; 2014 Jun; 134(11):2534-46. PubMed ID: 24293211
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane.
Penna A; Juvin V; Chemin J; Compan V; Monet M; Rassendren FA
Cell Calcium; 2006 Jun; 39(6):495-507. PubMed ID: 16533525
[TBL] [Abstract][Full Text] [Related]
11. Ca2+-dependent desensitization of TRPV2 channels is mediated by hydrolysis of phosphatidylinositol 4,5-bisphosphate.
Mercado J; Gordon-Shaag A; Zagotta WN; Gordon SE
J Neurosci; 2010 Oct; 30(40):13338-47. PubMed ID: 20926660
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of transient receptor potential channels in human endometrial stromal cells during the luteal phase of the menstrual cycle.
De Clercq K; Held K; Van Bree R; Meuleman C; Peeraer K; Tomassetti C; Voets T; D'Hooghe T; Vriens J
Hum Reprod; 2015 Jun; 30(6):1421-36. PubMed ID: 25820697
[TBL] [Abstract][Full Text] [Related]
13. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.
Yamada T; Ueda T; Shibata Y; Ikegami Y; Saito M; Ishida Y; Ugawa S; Kohri K; Shimada S
Urology; 2010 Aug; 76(2):509.e1-7. PubMed ID: 20546877
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide upregulates microglia phagocytosis and increases transient receptor potential vanilloid type 2 channel expression on the plasma membrane.
Maksoud MJE; Tellios V; An D; Xiang YY; Lu WY
Glia; 2019 Dec; 67(12):2294-2311. PubMed ID: 31453646
[TBL] [Abstract][Full Text] [Related]
15. Potential role of transient receptor potential (TRP) channels in bladder cancer cells.
Mizuno H; Suzuki Y; Watanabe M; Sokabe T; Yamamoto T; Hattori R; Gotoh M; Tominaga M
J Physiol Sci; 2014 Jul; 64(4):305-14. PubMed ID: 24849279
[TBL] [Abstract][Full Text] [Related]
16. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner.
Nabissi M; Morelli MB; Amantini C; Farfariello V; Ricci-Vitiani L; Caprodossi S; Arcella A; Santoni M; Giangaspero F; De Maria R; Santoni G
Carcinogenesis; 2010 May; 31(5):794-803. PubMed ID: 20093382
[TBL] [Abstract][Full Text] [Related]
17. Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells.
Liu Q; Wang X
Exp Ther Med; 2013 Nov; 6(5):1277-1282. PubMed ID: 24223658
[TBL] [Abstract][Full Text] [Related]
18. Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages.
Nagasawa M; Nakagawa Y; Tanaka S; Kojima I
J Cell Physiol; 2007 Mar; 210(3):692-702. PubMed ID: 17154364
[TBL] [Abstract][Full Text] [Related]
19. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
[TBL] [Abstract][Full Text] [Related]
20. TRPV2.
Kojima I; Nagasawa M
Handb Exp Pharmacol; 2014; 222():247-72. PubMed ID: 24756709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
